Community treatment orders: Current evidence and the implications

Abstract

Community treatment orders (CTOs) have been widely introduced to address the problems faced by 'revolving door' patients. A number of case-control studies have been conducted but show conflicting results concerning the effectiveness of CTOs. The Oxford Community Treatment Order Evaluation Trial (OCTET) is the third randomised controlled trial (RCT) to show that CTOs do not reduce rates of readmission over 12 months, despite restricting patients' autonomy. This evidence gives pause for thought about current CTO practice. Further high-quality RCTs may settle the contentious debate about effectiveness.